Richard M. Keenan

ANGIOTENSIN-II BLOCKADE IN MAN BY SAR1-ALA8-ANGIOTENSIN II FOR UNDERSTANDING AND TREATMENT OF HIGH BLOOD-PRESSURE

Hans R. Brunner, Haralambos Gavras, John H. Laragh et al. · The Lancet · 1973 · 243 citations

Hypertension, Cardiovascular Disease, Medicine +5

Identification and Biological Characterization of Heterocyclic Inhibitors of the Hepatitis C Virus RNA-dependent RNA Polymerase

Dashyant Dhanak, Kevin J. Duffy, Victor K. Johnston et al. · Journal of Biological Chemistry · 2002 · 196 citations · Full text

3-(1,1-Dioxo-2<i>H</i>-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1<i>H</i>)-quinolinones, Potent Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase

Rosanna Tedesco, Antony N. Shaw, Ramesh Bambal et al. · Journal of Medicinal Chemistry · 2006 · 159 citations · Full text

Identification of 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3<i>S</i>)-3-piperidinylmethyl]oxy}-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor of AKT Kinase

Dirk A. Heerding, Nelson Rhodes, Jack D. Leber et al. · Journal of Medicinal Chemistry · 2008 · 154 citations · Full text

Cell Death, Akt Kinase, Molecular Pharmacology +20

1-(Carboxybenzyl)imidazole-5-acrylic acids: potent and selective angiotensin II receptor antagonists

Joseph Weinstock, Richard M. Keenan, James M. Samanen et al. · Journal of Medicinal Chemistry · 1991 · 127 citations · Full text

Altmetric Attention Score, Pharmacotherapy, Pharmaceutical Chemistry +16